A Piece Of The Puzzle Missing From Fresenius Medical Care AG’s (ETR:FME) Share Price
There wouldn’t be many who think Fresenius Medical Care AG’s (ETR:FME) price-to-earnings (or “P/E”) ratio of 19.4x is worth a mention when the median P/E in Germany is similar at about 19x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/E.
With earnings growth that’s superior to most other companies of late, Fresenius Medical Care has been doing relatively well. It might be that many expect the strong earnings performance to wane, which has kept the P/E from rising. If not, then existing shareholders have reason to be feeling optimistic…
